You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,700,076


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,700,076
Title:Penetrating pharmaceutical foam
Abstract: The invention relates to an alcohol-free cosmetic or pharmaceutical foam composition comprising water, a hydrophobic solvent, a surface-active agent, a gelling agent, an active component selected from the group of urea, hydroxy acid and a therapeutic enhancer and a propellant. The foam further comprises active agents and excipients with therapeutic properties having enhanced skin penetration.
Inventor(s): Tamarkin; Dov (Maccabim, IL), Friedman; Doron (Karmei Yosef, IL), Eini; Meir (Ness Ziona, IL)
Assignee: Foamix, Ltd. (Ness Ziona, IT)
Application Number:10/922,358
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,700,076
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery;
Patent landscape, scope, and claims:

United States Patent 7,700,076: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,700,076, titled "Penetrating pharmaceutical foam," is a significant patent in the field of cosmetic and pharmaceutical formulations. This patent, granted to inventors associated with LEO Pharma A/S, pertains to an alcohol-free foam composition designed for various dermatological and cosmetic applications. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

The patent describes an alcohol-free cosmetic or pharmaceutical foam composition that includes water, a hydrophobic solvent, a surface-active agent, and an active agent. This composition is particularly useful for delivering active ingredients to the skin without the irritant effects of alcohol[2][4].

Composition and Ingredients

Water

The composition includes water as a primary solvent, which helps in creating a stable foam structure.

Hydrophobic Solvent

A hydrophobic solvent is incorporated to enhance the stability and penetration of the foam into the skin.

Surface-Active Agent

Surface-active agents, such as emulsifiers and surfactants, are crucial for creating and maintaining the foam structure.

Active Agent

The active agent can be any therapeutic or cosmetic ingredient, such as azelaic acid, which is commonly used for treating skin conditions like acne and rosacea.

Claims of the Patent

The patent includes several claims that define the scope of the invention. Here are some key claims:

Claim 1

Claim 1 is typically the broadest claim and defines the basic composition of the foam, including water, a hydrophobic solvent, a surface-active agent, and an active agent[2].

Subsequent Claims

Subsequent claims narrow down the scope by specifying particular types of hydrophobic solvents, surface-active agents, and active agents. These claims also include specific concentrations and ratios of the ingredients.

Importance of Claim Scope

The scope of the claims in a patent is critical for determining the level of protection and the likelihood of the patent being granted and upheld. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate due to issues such as the abstract idea exception and failure to meet the written description requirement[5].

Balancing Breadth and Specificity

The claims in US Patent 7,700,076 are crafted to balance breadth and specificity. While they are broad enough to cover a range of formulations, they are also anchored to specific embodiments disclosed in the specification. This balance is crucial for avoiding invalidation grounds and ensuring the patent's validity.

Patent Landscape and Litigation

Infringement Actions

The patent has been involved in several infringement actions. For instance, LEO Pharma A/S has asserted that Perrigo Pharmaceuticals has infringed on this patent through their submission of an Abbreviated New Drug Application (ANDA) for an azelaic acid foam product. This litigation highlights the importance of this patent in protecting the intellectual property rights of the inventors[4].

Related Patents

The patent is part of a larger portfolio of related patents held by LEO Pharma A/S. These patents collectively protect various aspects of the foam composition and its applications, ensuring comprehensive protection against infringement.

Metrics for Measuring Patent Scope

Research has shown that the scope of a patent can be measured using metrics such as independent claim length and independent claim count. These metrics can predict the likelihood of a patent being granted and the duration of the examination process. Narrower claims, like those in US Patent 7,700,076, are associated with a higher probability of grant and a shorter examination process[3].

Impact on Innovation

The patent landscape surrounding US Patent 7,700,076 influences innovation in the field of cosmetic and pharmaceutical formulations. By providing clear boundaries of what is protected, this patent encourages other inventors to develop new and distinct formulations, thereby driving innovation.

Industry Expert Insights

Industry experts emphasize the importance of getting the claim scope right. As noted by patent practitioners, "a patent with overly broad claims runs the risks of being invalidated." This highlights the need for careful drafting of claims to ensure they are both broad enough to provide meaningful protection and specific enough to avoid invalidation[5].

Statistics and Trends

  • Patent Maintenance Payments: Patents with narrower claims, like US Patent 7,700,076, tend to have lower maintenance payments, indicating a more focused and valid scope[3].
  • Forward Citations: The number of forward citations for this patent indicates its influence on subsequent inventions in the field.
  • Breadth of Patent Classes: The patent's classification within specific patent classes reflects its relevance and impact on the broader technological landscape.

Conclusion

United States Patent 7,700,076 is a significant invention in the field of cosmetic and pharmaceutical foams. The patent's scope and claims are carefully crafted to balance breadth and specificity, ensuring robust protection while avoiding common pitfalls like invalidation. The patent's involvement in litigation and its place within a larger portfolio of related patents underscore its importance in the intellectual property landscape.

Key Takeaways

  • Balanced Claim Scope: The patent's claims are balanced to ensure both breadth and specificity.
  • Infringement Actions: The patent has been involved in several infringement actions, highlighting its importance.
  • Metrics for Scope: Independent claim length and count are useful metrics for measuring patent scope.
  • Impact on Innovation: The patent encourages innovation by providing clear boundaries of protection.
  • Industry Insights: Experts emphasize the importance of careful claim drafting to avoid invalidation.

FAQs

Q: What is the main composition of the foam described in US Patent 7,700,076? A: The foam composition includes water, a hydrophobic solvent, a surface-active agent, and an active agent.

Q: Why is the claim scope important in a patent? A: The claim scope determines the level of protection and the likelihood of the patent being granted and upheld. It must balance breadth and specificity to avoid invalidation.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and independent claim count can be used to measure patent scope and predict the likelihood of grant and examination duration.

Q: How has US Patent 7,700,076 been involved in litigation? A: The patent has been involved in infringement actions, particularly against Perrigo Pharmaceuticals, regarding their ANDA submission for an azelaic acid foam product.

Q: What is the impact of this patent on innovation in the field? A: The patent encourages innovation by providing clear boundaries of protection, driving other inventors to develop new and distinct formulations.

Sources

  1. US7700076B2 - Penetrating pharmaceutical foam - Google Patents
  2. US Patent for Penetrating pharmaceutical foam Patent (Patent ... - Justia
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT ... - Rpxcorp
  5. The Importance of Getting the Claim Scope Right in a US Patent ... - Rimon Law

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,700,076

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Pharma As FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes 7,700,076 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,700,076

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel152486Oct 25, 2002

International Family Members for US Patent 7,700,076

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2003279493 ⤷  Subscribe
Australia 2004261063 ⤷  Subscribe
Australia 2004266502 ⤷  Subscribe
Australia 2004313285 ⤷  Subscribe
Australia 2004321183 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.